Peacock Bruce Insider Trades

Insider Trading History

Track insider trading activity for Peacock Bruce. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $150k 18,000 shares
Last Trade
Jun 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$243k 18,000 shares
$13.51
$8.35
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $210 15,000 shares
Last Trade
Feb 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221M 15,000 shares
$14,715.00
$0.01
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $91.9k 11,000 shares
Last Trade
Dec 03, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$475k 25,000 shares
$19.00
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $209k 25,000 shares
Last Trade
Dec 03, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$475k 25,000 shares
$19.00
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $0 0 shares
Last Trade
Dec 03, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$459k 25,000 shares
$18.36
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $150k 18,000 shares
Last Trade
Jun 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$158k 18,000 shares
$8.75
$8.35
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $124 8,886 shares
Last Trade
May 22, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$73.7M 3,500 shares
$21,060.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $49 3,500 shares
Last Trade
May 22, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$73.7M 3,500 shares
$21,060.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $560 40,000 shares
Last Trade
Jun 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.49B 40,000 shares
$37,260.00
$0.01
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $150k 18,000 shares
Last Trade
Jun 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.2k 18,000 shares
$3.90
$8.35
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $226 16,160 shares
Last Trade
Dec 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$513M 15,000 shares
$34,182.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $448 32,000 shares
Last Trade
Dec 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.09B 32,000 shares
$34,182.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $16.2 1,160 shares
Last Trade
Nov 21, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$21.5M 850 shares
$25,272.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $0 0 shares
Last Trade
Nov 21, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$430k 17 shares
$25,272.00
$0.01
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $150k 18,000 shares
Last Trade
Jun 14, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 18,000 shares
$8.14
$8.35
Ocular Therapeutix
Ocular Therapeutix OCUL
Director
Holding Value $113k 13,500 shares
Last Trade
Jun 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$145k 13,500 shares
$10.71
$8.35
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $0.238 17 shares
Last Trade
Feb 13, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.77M 17 shares
$221,940.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $238 17,000 shares
Last Trade
Feb 13, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.77B 17,000 shares
$221,940.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $210 15,000 shares
Last Trade
Aug 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.47B 15,000 shares
$298,080.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $87 6,211 shares
Last Trade
Aug 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3B 4,348 shares
$298,080.00
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up